Evidence map›Paper›PMID 41784173›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Multi-Organelle Stress-Induced Paraptosis by a ROS-Amplifying Nanocatalyst for Enhanced Cancer Immunotherapy.

Zhe Yu, Haozhe Ren, Hua Li, Jinghan Zhao, Miaomiao Cao, Tian Tang, Youbei Qiao, Liting Chen, Tiehong Yang, Hong Wu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhe YuDepartment of Pharmaceutical Analysis, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
Haozhe RenSchool of Stomatology, Lanzhou University, Lanzhou, China.
Hua LiDepartment of Chinese Materia Medica and Natural Medicines, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
Jinghan ZhaoDepartment of Pharmaceutical Analysis, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
Miaomiao CaoDepartment of Pharmaceutical Analysis, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
Tian TangDepartment of Pharmaceutical Analysis, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
Youbei QiaoDepartment of Pharmaceutical Analysis, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
Liting ChenDepartment of Radiation Oncology, Xijing Hospital, Air Force Medical University, The Fourth Military Medical University, Xi'an, China.
Tiehong YangDepartment of Pharmaceutical Analysis, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
Hong WuDepartment of Pharmaceutical Analysis, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.ORCID https://orcid.org/0000-0002-4939-5264

Funding

"Clinical Medicine + Pharmacy" Research Project of Xijing Hospital LHJJ2023-YX12National Natural Science Foundation of China 32171388Natural Science Foundation of Shaanxi Province 2024JC-YBQN-0941Shaanxi Provincial Key Research and Development Program 2022-ZDLSF05-17Shaanxi Provincial Key Research and Development Program 2023-YBSF-504Shaanxi Provincial Key Research and Development Program 2023-ZDLSF-57Xijing Hospital Interdisciplinary Medical Research Promotion Special Program XJZT24JC05
6 · The paper itself

Abstract

Chemodynamic therapy (CDT) is severely limited by inadequate intracellular H

Indexed as

ImmunotherapyNeoplasmsParaptosisReactive Oxygen SpeciesAnimalsAutophagyCell Line, TumorHumansMiceTumor MicroenvironmentReactive Oxygen Speciesautophagychemodynamic therapyendoplasmic reticulum stressimmunogenic cell deathmitochondrial dysfunctionparaptosis

Identifiers

PMID41784173
PMCPMC13159107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.